Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Insulin Glargine Formulation vs Lantus in Japanese T2DM
NCT01689142Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2012
- Primary completion
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Sep 2012; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01689142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689142.